BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1390932 Nc1cc(Nc2c3CCCc3c3C(=O)NC4(CCCCC4)n3c2=O)ncn1 InChI=1S/C19H22N6O2/c20-13-9-14(22-10-21-13)23-15-11-5-4-6-12(11)16-17(26)24-19(25(16)18(15)27)7-2-1-3-8-19/h9-10H,1-8H2,(H,24,26)(H3,20,21,22,23) DDWYHDFOOZOEOH-UHFFFAOYSA-N 660321 US20240092799, Compound I MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660321 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660321&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 169086866 496708815 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1390933 Nc1cc(Nc2c3CCCc3c3C(=O)NC4(CCCCC4)n3c2=O)ncn1 InChI=1S/C19H22N6O2/c20-13-9-14(22-10-21-13)23-15-11-5-4-6-12(11)16-17(26)24-19(25(16)18(15)27)7-2-1-3-8-19/h9-10H,1-8H2,(H,24,26)(H3,20,21,22,23) DDWYHDFOOZOEOH-UHFFFAOYSA-N 660321 US20240092799, Compound I MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660321 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660321&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086866 496708815 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390934 Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21C[C@H]2CC[C@@H]1C2 |r| InChI=1S/C18H20N6O2/c1-9-4-12(22-14-6-13(19)20-8-21-14)17(26)24-15(9)16(25)23-18(24)7-10-2-3-11(18)5-10/h4,6,8,10-11H,2-3,5,7H2,1H3,(H,23,25)(H3,19,20,21,22) OROGTVJVVOAHJX-UHFFFAOYSA-N 660325 US20240092799, Compound IIa MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660325&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 171665255 496708819 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1390935 Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21C[C@H]2CC[C@@H]1C2 |r| InChI=1S/C18H20N6O2/c1-9-4-12(22-14-6-13(19)20-8-21-14)17(26)24-15(9)16(25)23-18(24)7-10-2-3-11(18)5-10/h4,6,8,10-11H,2-3,5,7H2,1H3,(H,23,25)(H3,19,20,21,22) OROGTVJVVOAHJX-UHFFFAOYSA-N 660325 US20240092799, Compound IIa MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660325 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660325&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171665255 496708819 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390936 Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21C[C@@H]2CC[C@H]1C2 |r| InChI=1S/C18H20N6O2/c1-9-4-12(22-14-6-13(19)20-8-21-14)17(26)24-15(9)16(25)23-18(24)7-10-2-3-11(18)5-10/h4,6,8,10-11H,2-3,5,7H2,1H3,(H,23,25)(H3,19,20,21,22) OROGTVJVVOAHJX-UHFFFAOYSA-N 660326 US20240092799, Compound IIb MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660326 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660326&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 171665256 496708820 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1390937 Cc1cc(Nc2cc(N)ncn2)c(=O)n2c1C(=O)NC21C[C@@H]2CC[C@H]1C2 |r| InChI=1S/C18H20N6O2/c1-9-4-12(22-14-6-13(19)20-8-21-14)17(26)24-15(9)16(25)23-18(24)7-10-2-3-11(18)5-10/h4,6,8,10-11H,2-3,5,7H2,1H3,(H,23,25)(H3,19,20,21,22) OROGTVJVVOAHJX-UHFFFAOYSA-N 660326 US20240092799, Compound IIb MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660326 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660326&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171665256 496708820 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390938 Nc1cc(Nc2c3ccccc3c3C(=O)NC4(CCCCC4)n3c2=O)ncn1 InChI=1S/C20H20N6O2/c21-14-10-15(23-11-22-14)24-16-12-6-2-3-7-13(12)17-18(27)25-20(26(17)19(16)28)8-4-1-5-9-20/h2-3,6-7,10-11H,1,4-5,8-9H2,(H,25,27)(H3,21,22,23,24) DOFIKDKXFMYNGQ-UHFFFAOYSA-N 660327 US20240092799, Compound III MAP kinase-interacting serine/threonine-protein kinase 1 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660327 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3672&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660327&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+1&column=ki&startPg=0&Increment=50&submit=Search 163525271 496708821 1 MVSSQKLEKPIEMGSSEPLPIADGDRRRKKKRRGRATDSLPGKFEDMYKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKDKVSLCHLGWSAMAPSGLTAAPTSLGSSDPPTSASQVAGTTGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEENELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGEDRSPPTAL MAP kinase-interacting serine/threonine-protein kinase 1 MKNK1_HUMAN Q9BUB5 D3DQ20 D3DQ21 O00312 Q5TC06 Q5TC07 Q6V0N6 1390939 Nc1cc(Nc2c3ccccc3c3C(=O)NC4(CCCCC4)n3c2=O)ncn1 InChI=1S/C20H20N6O2/c21-14-10-15(23-11-22-14)24-16-12-6-2-3-7-13(12)17-18(27)25-20(26(17)19(16)28)8-4-1-5-9-20/h2-3,6-7,10-11H,1,4-5,8-9H2,(H,25,27)(H3,21,22,23,24) DOFIKDKXFMYNGQ-UHFFFAOYSA-N 660327 US20240092799, Compound III MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660327 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660327&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163525271 496708821 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390940 Cc1cc(cc2c1C(=O)NC21CCCCC1)-c1cc(no1)-c1cc(N)ncn1 InChI=1S/C21H21N5O2/c1-12-7-13(17-9-16(26-28-17)15-10-18(22)24-11-23-15)8-14-19(12)20(27)25-21(14)5-3-2-4-6-21/h7-11H,2-6H2,1H3,(H,25,27)(H2,22,23,24) NSHZTXBHXJQGBK-UHFFFAOYSA-N 660328 US20240092799, Compound VII MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660328 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660328&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086782 496708822 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390941 Nc1cc(Nc2cc3c(s2)C(=O)NC32CCNCC2)ncn1 InChI=1S/C14H16N6OS/c15-9-6-10(18-7-17-9)19-11-5-8-12(22-11)13(21)20-14(8)1-3-16-4-2-14/h5-7,16H,1-4H2,(H,20,21)(H3,15,17,18,19) OPCIUFPDZTXBKC-UHFFFAOYSA-N 660329 US20240092799, Compound VIII-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660329 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660329&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086924 496708823 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390942 Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C15H17N5OS/c16-10-7-11(18-8-17-10)19-12-6-9-13(22-12)14(21)20-15(9)4-2-1-3-5-15/h6-8H,1-5H2,(H,20,21)(H3,16,17,18,19) MOFJJAKCBCFGBO-UHFFFAOYSA-N 660330 US20240092799, Compound X MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660330 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660330&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086926 496708824 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390943 O=C1NC2(CCCCC2)c2cc(Nc3ccncn3)sc12 InChI=1S/C15H16N4OS/c20-14-13-10(15(19-14)5-2-1-3-6-15)8-12(21-13)18-11-4-7-16-9-17-11/h4,7-9H,1-3,5-6H2,(H,19,20)(H,16,17,18) UTKWEUQAYNTLKC-UHFFFAOYSA-N 660331 US20240092799, Compound X-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660331 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660331&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086788 496708825 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390944 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4sccc34)sc12 InChI=1S/C17H16N4OS2/c22-15-13-11(17(21-15)5-2-1-3-6-17)8-12(24-13)20-14-10-4-7-23-16(10)19-9-18-14/h4,7-9H,1-3,5-6H2,(H,21,22)(H,18,19,20) QUYCWDXZKIPQCE-UHFFFAOYSA-N 660332 US20240092799, Compound X-B MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660332 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660332&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163914360 496708826 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390945 COc1c(N)ncnc1Nc1cc2c(s1)C(=O)NC21CCCCC1 InChI=1S/C16H19N5O2S/c1-23-11-13(17)18-8-19-14(11)20-10-7-9-12(24-10)15(22)21-16(9)5-3-2-4-6-16/h7-8H,2-6H2,1H3,(H,21,22)(H3,17,18,19,20) MITHVBXNXXYSDU-UHFFFAOYSA-N 660333 US20240092799, Compound X-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660333 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660333&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086774 496708827 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390946 Cc1c(N)ncnc1Nc1cc2c(s1)C(=O)NC21CCCCC1 InChI=1S/C16H19N5OS/c1-9-13(17)18-8-19-14(9)20-11-7-10-12(23-11)15(22)21-16(10)5-3-2-4-6-16/h7-8H,2-6H2,1H3,(H,21,22)(H3,17,18,19,20) IEAVJAADOSYFMU-UHFFFAOYSA-N 660334 US20240092799, Compound X-D MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660334 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660334&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086764 496708828 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390947 Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCC2)ncn1 InChI=1S/C14H15N5OS/c15-9-6-10(17-7-16-9)18-11-5-8-12(21-11)13(20)19-14(8)3-1-2-4-14/h5-7H,1-4H2,(H,19,20)(H3,15,16,17,18) BLFHEZXLQIRACW-UHFFFAOYSA-N 660335 US20240092799, Compound X-E MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660335 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660335&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086933 496708829 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390948 Nc1cc(Nc2cc3C(=O)NC4(CCCCC4)n3n2)ncn1 InChI=1S/C14H17N7O/c15-10-7-11(17-8-16-10)18-12-6-9-13(22)19-14(21(9)20-12)4-2-1-3-5-14/h6-8H,1-5H2,(H,19,22)(H3,15,16,17,18,20) ZPSXTUATGHDIJC-UHFFFAOYSA-N 660336 US20240092799, Compound XI MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660336 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660336&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086803 496708830 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390949 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4[nH]cnc34)sc12 InChI=1S/C16H16N6OS/c23-15-12-9(16(22-15)4-2-1-3-5-16)6-10(24-12)21-14-11-13(18-7-17-11)19-8-20-14/h6-8H,1-5H2,(H,22,23)(H2,17,18,19,20,21) IDXLCVBPMBJKMH-UHFFFAOYSA-N 660337 US20240092799, Compound XVII MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660337 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660337&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086879 496708831 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390950 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4[nH]ccc34)sc12 InChI=1S/C17H17N5OS/c23-16-13-11(17(22-16)5-2-1-3-6-17)8-12(24-13)21-15-10-4-7-18-14(10)19-9-20-15/h4,7-9H,1-3,5-6H2,(H,22,23)(H2,18,19,20,21) BRRFBENTOMICNT-UHFFFAOYSA-N 660338 US20240092799, Compound XVII-A::US20240092799, Compound XXVIII-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660338&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163464854 496708832 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390951 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4[nH]ncc34)sc12 InChI=1S/C16H16N6OS/c23-15-12-10(16(21-15)4-2-1-3-5-16)6-11(24-12)20-13-9-7-19-22-14(9)18-8-17-13/h6-8H,1-5H2,(H,21,23)(H2,17,18,19,20,22) KWUNBLJVZFTWPK-UHFFFAOYSA-N 660339 US20240092799, Compound XVII-B MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660339 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660339&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086931 496708833 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390952 Cc1cc2c(Nc3cc4c(s3)C(=O)NC43CCCCC3)ncnc2[nH]1 InChI=1S/C18H19N5OS/c1-10-7-11-15(21-10)19-9-20-16(11)22-13-8-12-14(25-13)17(24)23-18(12)5-3-2-4-6-18/h7-9H,2-6H2,1H3,(H,23,24)(H2,19,20,21,22) LDQPLJGHQGXPCX-UHFFFAOYSA-N 660340 US20240092799, Compound XVII-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660340 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660340&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086906 496708834 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390953 Cc1cc(-c2cc(no2)-c2cc(N)ncn2)c(=O)n2c1C(=O)NC21CCCCC1 InChI=1S/C20H20N6O3/c1-11-7-12(15-8-14(25-29-15)13-9-16(21)23-10-22-13)19(28)26-17(11)18(27)24-20(26)5-3-2-4-6-20/h7-10H,2-6H2,1H3,(H,24,27)(H2,21,22,23) YCCMTQMVPLABCH-UHFFFAOYSA-N 660341 US20240092799, Compound XVIII MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660341 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660341&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086765 496708835 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390954 CSc1ncc2c(n[nH]c2n1)-c1cc2c(s1)C(=O)NC21CCCCC1 InChI=1S/C17H17N5OS2/c1-24-16-18-8-9-12(21-22-14(9)19-16)11-7-10-13(25-11)15(23)20-17(10)5-3-2-4-6-17/h7-8H,2-6H2,1H3,(H,20,23)(H,18,19,21,22) JABBUCSWTVADCK-UHFFFAOYSA-N 660342 US20240092799, Compound XIX MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660342 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660342&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086898 496708836 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390955 Nc1ncnc(Nc2cc3c(s2)C(=O)NC32CCCCC2)c1Cl InChI=1S/C15H16ClN5OS/c16-10-12(17)18-7-19-13(10)20-9-6-8-11(23-9)14(22)21-15(8)4-2-1-3-5-15/h6-7H,1-5H2,(H,21,22)(H3,17,18,19,20) YXPJWNVHHQFZKJ-UHFFFAOYSA-N 660343 US20240092799, Compound XX MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660343 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660343&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086814 496708837 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390956 Clc1c(NC(=O)C2CC2)ncnc1Nc1cc2c(s1)C(=O)NC21CCCCC1 InChI=1S/C19H20ClN5O2S/c20-13-15(21-9-22-16(13)24-17(26)10-4-5-10)23-12-8-11-14(28-12)18(27)25-19(11)6-2-1-3-7-19/h8-10H,1-7H2,(H,25,27)(H2,21,22,23,24,26) BSXBISPVHAWHSO-UHFFFAOYSA-N 660344 US20240092799, Compound XX-7 MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660344 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660344&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086890 496708838 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390957 O=C(Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1)C1CC1 InChI=1S/C19H21N5O2S/c25-17(11-4-5-11)23-14-9-13(20-10-21-14)22-15-8-12-16(27-15)18(26)24-19(12)6-2-1-3-7-19/h8-11H,1-7H2,(H,24,26)(H2,20,21,22,23,25) UTFDDTLQEZNKJH-UHFFFAOYSA-N 660345 US20240092799, Compound XX-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660345 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660345&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086796 496708839 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390958 COc1c(NC(=O)C2CC2)ncnc1Nc1cc2c(s1)C(=O)NC21CCCCC1 InChI=1S/C20H23N5O3S/c1-28-14-16(21-10-22-17(14)24-18(26)11-5-6-11)23-13-9-12-15(29-13)19(27)25-20(12)7-3-2-4-8-20/h9-11H,2-8H2,1H3,(H,25,27)(H2,21,22,23,24,26) VWSSRMGBILQQEF-UHFFFAOYSA-N 660346 US20240092799, Compound XX-B MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660346 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660346&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086903 496708840 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390959 Cc1c(NC(=O)C2CC2)ncnc1Nc1cc2c(s1)C(=O)NC21CCCCC1 InChI=1S/C20H23N5O2S/c1-11-16(21-10-22-17(11)24-18(26)12-5-6-12)23-14-9-13-15(28-14)19(27)25-20(13)7-3-2-4-8-20/h9-10,12H,2-8H2,1H3,(H,25,27)(H2,21,22,23,24,26) PPSBGKBSJFFXEF-UHFFFAOYSA-N 660347 US20240092799, Compound XX-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660347 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660347&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086908 496708841 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390960 O=C(Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1)C1CCCC1 InChI=1S/C21H25N5O2S/c27-19(13-6-2-3-7-13)25-16-11-15(22-12-23-16)24-17-10-14-18(29-17)20(28)26-21(14)8-4-1-5-9-21/h10-13H,1-9H2,(H,26,28)(H2,22,23,24,25,27) GSKNOJSYXRDWCJ-UHFFFAOYSA-N 660348 US20240092799, Compound XX-D MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660348 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660348&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086891 496708842 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390961 O=C(Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1)c1ccccc1 InChI=1S/C22H21N5O2S/c28-20(14-7-3-1-4-8-14)26-17-12-16(23-13-24-17)25-18-11-15-19(30-18)21(29)27-22(15)9-5-2-6-10-22/h1,3-4,7-8,11-13H,2,5-6,9-10H2,(H,27,29)(H2,23,24,25,26,28) PGAVKORCJYTWNB-UHFFFAOYSA-N 660349 US20240092799, Compound XX-E MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660349 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660349&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163865223 496708843 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390962 Nc1cc(Cc2sc3C(=O)NC4(CCCCC4)c3c2Cl)ncn1 InChI=1S/C16H17ClN4OS/c17-13-10(6-9-7-11(18)20-8-19-9)23-14-12(13)16(21-15(14)22)4-2-1-3-5-16/h7-8H,1-6H2,(H,21,22)(H2,18,19,20) TUXXTCYTFBIXFK-UHFFFAOYSA-N 660350 US20240092799, Compound XXI MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660350 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660350&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053857 496708844 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390963 Clc1c(Nc2cc(N[C@H]3CCOC3)ncn2)sc2C(=O)NC3(CCCCC3)c12 |r| InChI=1S/C19H22ClN5O2S/c20-15-14-16(17(26)25-19(14)5-2-1-3-6-19)28-18(15)24-13-8-12(21-10-22-13)23-11-4-7-27-9-11/h8,10-11H,1-7,9H2,(H,25,26)(H2,21,22,23,24) NWNWQVNLGIOFIP-UHFFFAOYSA-N 660351 US20240092799, Compound XXI-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660351 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660351&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086916 496708845 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390964 Nc1cc(Nc2cc3c(s2)C(=O)NC32CCOCC2)ncn1 InChI=1S/C14H15N5O2S/c15-9-6-10(17-7-16-9)18-11-5-8-12(22-11)13(20)19-14(8)1-3-21-4-2-14/h5-7H,1-4H2,(H,19,20)(H3,15,16,17,18) ZSUPFDAXFPMOHC-UHFFFAOYSA-N 660352 US20240092799, Compound XXII MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660352 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660352&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 164167961 496708846 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390965 CNc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C16H19N5OS/c1-17-11-8-12(19-9-18-11)20-13-7-10-14(23-13)15(22)21-16(10)5-3-2-4-6-16/h7-9H,2-6H2,1H3,(H,21,22)(H2,17,18,19,20) YHBLSQNTDIEPNV-UHFFFAOYSA-N 660353 US20240092799, Compound XXIII MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660353 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660353&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086777 496708847 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390966 CN(C)CCNc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C19H26N6OS/c1-25(2)9-8-20-14-11-15(22-12-21-14)23-16-10-13-17(27-16)18(26)24-19(13)6-4-3-5-7-19/h10-12H,3-9H2,1-2H3,(H,24,26)(H2,20,21,22,23) FQYSEBQBSIZTMP-UHFFFAOYSA-N 660354 US20240092799, Compound XXIII-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660354 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660354&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086868 496708848 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390967 O=C1NC2(CCCCC2)c2cc(Nc3cc(Nc4ccccc4)ncn3)sc12 InChI=1S/C21H21N5OS/c27-20-19-15(21(26-20)9-5-2-6-10-21)11-18(28-19)25-17-12-16(22-13-23-17)24-14-7-3-1-4-8-14/h1,3-4,7-8,11-13H,2,5-6,9-10H2,(H,26,27)(H2,22,23,24,25) VPDWJTIJIICZOP-UHFFFAOYSA-N 660355 US20240092799, Compound XXIII-B MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660355 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660355&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086772 496708849 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390968 O=C1NC2(CCCCC2)c2cc(Nc3cc(Nc4ccccn4)ncn3)sc12 InChI=1S/C20H20N6OS/c27-19-18-13(20(26-19)7-3-1-4-8-20)10-17(28-18)25-16-11-15(22-12-23-16)24-14-6-2-5-9-21-14/h2,5-6,9-12H,1,3-4,7-8H2,(H,26,27)(H2,21,22,23,24,25) SCZZXUINUZXVNI-UHFFFAOYSA-N 660356 US20240092799, Compound XXIII-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660356 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660356&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086828 496708850 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390969 NC1CCN(C1)c1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C19H24N6OS/c20-12-4-7-25(10-12)15-9-14(21-11-22-15)23-16-8-13-17(27-16)18(26)24-19(13)5-2-1-3-6-19/h8-9,11-12H,1-7,10,20H2,(H,24,26)(H,21,22,23) XEEXVFCIILICCT-UHFFFAOYSA-N 660357 US20240092799, Compound XXIII-D MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660357 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660357&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 164088752 496708851 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390970 O=C1NC2(CCCCC2)c2cc(Nc3cc(ncn3)N3CCCCC3)sc12 InChI=1S/C20H25N5OS/c26-19-18-14(20(24-19)7-3-1-4-8-20)11-17(27-18)23-15-12-16(22-13-21-15)25-9-5-2-6-10-25/h11-13H,1-10H2,(H,24,26)(H,21,22,23) RLGKOPJENJTWPZ-UHFFFAOYSA-N 660358 US20240092799, Compound XXIII-E MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660358 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660358&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086925 496708852 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390971 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4sc5CCCCc5c34)sc12 InChI=1S/C21H22N4OS2/c26-19-17-13(21(25-19)8-4-1-5-9-21)10-15(28-17)24-18-16-12-6-2-3-7-14(12)27-20(16)23-11-22-18/h10-11H,1-9H2,(H,25,26)(H,22,23,24) SLIDHAUNYZMDNM-UHFFFAOYSA-N 660359 US20240092799, Compound XXIII-F MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660359 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660359&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086804 496708853 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390972 Clc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C15H15ClN4OS/c16-10-7-11(18-8-17-10)19-12-6-9-13(22-12)14(21)20-15(9)4-2-1-3-5-15/h6-8H,1-5H2,(H,20,21)(H,17,18,19) BYOYPIKBHWVSPJ-UHFFFAOYSA-N 660360 US20240092799, Compound XXIII-G MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660360 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660360&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086874 496708854 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390973 O=C1NC2(CCCCC2)c2cc(Nc3cc(ncn3)N3CCCC3)sc12 InChI=1S/C19H23N5OS/c25-18-17-13(19(23-18)6-2-1-3-7-19)10-16(26-17)22-14-11-15(21-12-20-14)24-8-4-5-9-24/h10-12H,1-9H2,(H,23,25)(H,20,21,22) DSQXUZWLRIEHFU-UHFFFAOYSA-N 660361 US20240092799, Compound XXIII-H MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660361 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660361&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086885 496708855 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390974 Cc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C16H18N4OS/c1-10-7-12(18-9-17-10)19-13-8-11-14(22-13)15(21)20-16(11)5-3-2-4-6-16/h7-9H,2-6H2,1H3,(H,20,21)(H,17,18,19) DFCHFWFLVDIVMX-UHFFFAOYSA-N 660362 US20240092799, Compound XXIII-I MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660362 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660362&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086856 496708856 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390975 OCCNc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C17H21N5O2S/c23-7-6-18-12-9-13(20-10-19-12)21-14-8-11-15(25-14)16(24)22-17(11)4-2-1-3-5-17/h8-10,23H,1-7H2,(H,22,24)(H2,18,19,20,21) HSSRCFKGHQZRKB-UHFFFAOYSA-N 660363 US20240092799, Compound XXIII-J MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660363 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660363&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086826 496708857 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390976 O=C1NC2(CCCCC2)c2cc(Nc3cc(ncn3)N3CCOCC3)sc12 InChI=1S/C19H23N5O2S/c25-18-17-13(19(23-18)4-2-1-3-5-19)10-16(27-17)22-14-11-15(21-12-20-14)24-6-8-26-9-7-24/h10-12H,1-9H2,(H,23,25)(H,20,21,22) XMCHTRIRLUJIOG-UHFFFAOYSA-N 660364 US20240092799, Compound XXIII-K MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660364 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660364&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053876 496708858 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390977 FC1(F)CCN(CC1)c1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C20H23F2N5OS/c21-20(22)6-8-27(9-7-20)15-11-14(23-12-24-15)25-16-10-13-17(29-16)18(28)26-19(13)4-2-1-3-5-19/h10-12H,1-9H2,(H,26,28)(H,23,24,25) PXALVTRYXMXSQE-UHFFFAOYSA-N 660365 US20240092799, Compound XXIII-L MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660365 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660365&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086816 496708859 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390978 CN1CCN(CC1)c1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C20H26N6OS/c1-25-7-9-26(10-8-25)16-12-15(21-13-22-16)23-17-11-14-18(28-17)19(27)24-20(14)5-3-2-4-6-20/h11-13H,2-10H2,1H3,(H,24,27)(H,21,22,23) MXYWUFRCNMBVOY-UHFFFAOYSA-N 660366 US20240092799, Compound XXIII-M MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660366 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660366&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086932 496708860 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390979 O=C1NC2(CCCCC2)c2cc(Nc3cc(NC4CCCC4)ncn3)sc12 InChI=1S/C20H25N5OS/c26-19-18-14(20(25-19)8-4-1-5-9-20)10-17(27-18)24-16-11-15(21-12-22-16)23-13-6-2-3-7-13/h10-13H,1-9H2,(H,25,26)(H2,21,22,23,24) ZJGASNMSZSJECF-UHFFFAOYSA-N 660367 US20240092799, Compound XXIII-N MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660367 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660367&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086884 496708861 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390980 O=C1NC2(CCCCC2)c2cc(Nc3cc(Nc4ccncc4)ncn3)sc12 InChI=1S/C20H20N6OS/c27-19-18-14(20(26-19)6-2-1-3-7-20)10-17(28-18)25-16-11-15(22-12-23-16)24-13-4-8-21-9-5-13/h4-5,8-12H,1-3,6-7H2,(H,26,27)(H2,21,22,23,24,25) XETKRWZYRWIQAS-UHFFFAOYSA-N 660368 US20240092799, Compound XXIII-O MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660368 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660368&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 164089388 496708862 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390981 Cn1ccc(Nc2cc(Nc3cc4c(s3)C(=O)NC43CCCCC3)ncn2)n1 InChI=1S/C19H21N7OS/c1-26-8-5-13(25-26)22-14-10-15(21-11-20-14)23-16-9-12-17(28-16)18(27)24-19(12)6-3-2-4-7-19/h5,8-11H,2-4,6-7H2,1H3,(H,24,27)(H2,20,21,22,23,25) PHRYFXHCQZSODC-UHFFFAOYSA-N 660369 US20240092799, Compound XXIII-P MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660369 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660369&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086875 496708863 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390982 O=C1NC2(CCCCC2)c2cc(Nc3cc(NCC4CCCO4)ncn3)sc12 InChI=1S/C20H25N5O2S/c26-19-18-14(20(25-19)6-2-1-3-7-20)9-17(28-18)24-16-10-15(22-12-23-16)21-11-13-5-4-8-27-13/h9-10,12-13H,1-8,11H2,(H,25,26)(H2,21,22,23,24) WPKXBGUWSZKEOQ-UHFFFAOYSA-N 660370 US20240092799, Compound XXIII-Q MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660370 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660370&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 164071339 496708864 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390983 O=C1NC2(CCCCC2)c2cc(Nc3cc(NC4CCNC4)ncn3)sc12 InChI=1S/C19H24N6OS/c26-18-17-13(19(25-18)5-2-1-3-6-19)8-16(27-17)24-15-9-14(21-11-22-15)23-12-4-7-20-10-12/h8-9,11-12,20H,1-7,10H2,(H,25,26)(H2,21,22,23,24) LGDSGMHCIMTMBA-UHFFFAOYSA-N 660371 US20240092799, Compound XXIII-R MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660371 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660371&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163739033 496708865 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390984 Cc1cccnc1Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C21H22N6OS/c1-13-6-5-9-22-19(13)26-16-11-15(23-12-24-16)25-17-10-14-18(29-17)20(28)27-21(14)7-3-2-4-8-21/h5-6,9-12H,2-4,7-8H2,1H3,(H,27,28)(H2,22,23,24,25,26) RBERFHVRQICOMJ-UHFFFAOYSA-N 660372 US20240092799, Compound XXIII-S MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660372 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660372&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086827 496708866 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390985 CN1CCN(CC1)c1ccc(Nc2cc(Nc3cc4c(s3)C(=O)NC43CCCCC3)ncn2)nc1 InChI=1S/C25H30N8OS/c1-32-9-11-33(12-10-32)17-5-6-19(26-15-17)29-20-14-21(28-16-27-20)30-22-13-18-23(35-22)24(34)31-25(18)7-3-2-4-8-25/h5-6,13-16H,2-4,7-12H2,1H3,(H,31,34)(H2,26,27,28,29,30) KHICWQZLUZMYKU-UHFFFAOYSA-N 660373 US20240092799, Compound XXIII-T MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660373 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660373&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086809 496708867 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390986 O=C1NC2(CCCCC2)c2cc(Nc3cc(Nc4cc[nH]n4)ncn3)sc12 InChI=1S/C18H19N7OS/c26-17-16-11(18(24-17)5-2-1-3-6-18)8-15(27-16)23-14-9-13(19-10-20-14)22-12-4-7-21-25-12/h4,7-10H,1-3,5-6H2,(H,24,26)(H3,19,20,21,22,23,25) NJZOMXYTIYNJEE-UHFFFAOYSA-N 660374 US20240092799, Compound XXIII-U MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660374 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660374&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086902 496708868 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390987 O=C(Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1)C1CCNC1 InChI=1S/C20H24N6O2S/c27-18(12-4-7-21-10-12)25-15-9-14(22-11-23-15)24-16-8-13-17(29-16)19(28)26-20(13)5-2-1-3-6-20/h8-9,11-12,21H,1-7,10H2,(H,26,28)(H2,22,23,24,25,27) SFQWEHCKTFUZPP-UHFFFAOYSA-N 660375 US20240092799, Compound XXIII-V MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660375 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660375&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086935 496708869 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390988 COCCNc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C18H23N5O2S/c1-25-8-7-19-13-10-14(21-11-20-13)22-15-9-12-16(26-15)17(24)23-18(12)5-3-2-4-6-18/h9-11H,2-8H2,1H3,(H,23,24)(H2,19,20,21,22) TXRWXGUIZZXNQM-UHFFFAOYSA-N 660376 US20240092799, Compound XXIII-W MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660376 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660376&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086831 496708870 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390989 O[C@H]1CCC[C@@H]1Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 |r| InChI=1S/C20H25N5O2S/c26-14-6-4-5-13(14)23-15-10-16(22-11-21-15)24-17-9-12-18(28-17)19(27)25-20(12)7-2-1-3-8-20/h9-11,13-14,26H,1-8H2,(H,25,27)(H2,21,22,23,24) XOICDSTYFUYKPF-UHFFFAOYSA-N 660377 US20240092799, Compound XXIII-X MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660377 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660377&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086860 496708871 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390990 O=C1NC2(CCCCC2)c2cc(Nc3cc(NC4CCOC4)ncn3)sc12 InChI=1S/C19H23N5O2S/c25-18-17-13(19(24-18)5-2-1-3-6-19)8-16(27-17)23-15-9-14(20-11-21-15)22-12-4-7-26-10-12/h8-9,11-12H,1-7,10H2,(H,24,25)(H2,20,21,22,23) OYSMSNUGRIEMET-UHFFFAOYSA-N 660378 US20240092799, Compound XXIII-Y MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660378 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660378&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163856470 496708872 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390991 O=C1NC2(CCCCC2)c2cc(Nc3cc(Nc4cccnc4)ncn3)sc12 InChI=1S/C20H20N6OS/c27-19-18-14(20(26-19)6-2-1-3-7-20)9-17(28-18)25-16-10-15(22-12-23-16)24-13-5-4-8-21-11-13/h4-5,8-12H,1-3,6-7H2,(H,26,27)(H2,22,23,24,25) BSOCWFZNGYHEKH-UHFFFAOYSA-N 660379 US20240092799, Compound XXIII-Z MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660379 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660379&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053869 496708873 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390992 O=C1NC2(CCCCC2)c2cc(Nc3cc(NCc4cccs4)ncn3)sc12 InChI=1S/C20H21N5OS2/c26-19-18-14(20(25-19)6-2-1-3-7-20)9-17(28-18)24-16-10-15(22-12-23-16)21-11-13-5-4-8-27-13/h4-5,8-10,12H,1-3,6-7,11H2,(H,25,26)(H2,21,22,23,24) RKGLJOYSOVCCKF-UHFFFAOYSA-N 660380 US20240092799, Compound XXIV MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660380 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660380&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086841 496708874 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390993 O=C1NC2(CCCCC2)c2cc(Nc3cc(N[C@H]4CCCOC4)ncn3)sc12 |r| InChI=1S/C20H25N5O2S/c26-19-18-14(20(25-19)6-2-1-3-7-20)9-17(28-18)24-16-10-15(21-12-22-16)23-13-5-4-8-27-11-13/h9-10,12-13H,1-8,11H2,(H,25,26)(H2,21,22,23,24) QXGVOVDGDLVNBW-UHFFFAOYSA-N 660381 US20240092799, Compound XXIV-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660381 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660381&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163917181 496708875 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390994 O=C1NC2(CCCCC2)c2cc(Nc3cc(N[C@H]4CCOC4)ncn3)sc12 |r| InChI=1S/C19H23N5O2S/c25-18-17-13(19(24-18)5-2-1-3-6-19)8-16(27-17)23-15-9-14(20-11-21-15)22-12-4-7-26-10-12/h8-9,11-12H,1-7,10H2,(H,24,25)(H2,20,21,22,23) OYSMSNUGRIEMET-UHFFFAOYSA-N 660382 US20240092799, Compound XXIV-B::US20240092799, Compound XXIV-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660382 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660382&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086847 496708876 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390995 O=C1NC2(CCCCC2)c2cc(Nc3cc(N[C@H]4CCOC4)ncn3)sc12 |r| InChI=1S/C19H23N5O2S/c25-18-17-13(19(24-18)5-2-1-3-6-19)8-16(27-17)23-15-9-14(20-11-21-15)22-12-4-7-26-10-12/h8-9,11-12H,1-7,10H2,(H,24,25)(H2,20,21,22,23) OYSMSNUGRIEMET-UHFFFAOYSA-N 660382 US20240092799, Compound XXIV-B::US20240092799, Compound XXIV-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660382 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660382&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086847 496708876 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390996 O=C1NC2(CCCCC2)c2cc(Nc3cc(NC4CCOCC4)ncn3)sc12 InChI=1S/C20H25N5O2S/c26-19-18-14(20(25-19)6-2-1-3-7-20)10-17(28-18)24-16-11-15(21-12-22-16)23-13-4-8-27-9-5-13/h10-13H,1-9H2,(H,25,26)(H2,21,22,23,24) JTKQUYOGGNCFCN-UHFFFAOYSA-N 660384 US20240092799, Compound XXIV-D MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660384 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660384&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086839 496708877 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390997 Fc1ccccc1Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C21H20FN5OS/c22-14-6-2-3-7-15(14)25-16-11-17(24-12-23-16)26-18-10-13-19(29-18)20(28)27-21(13)8-4-1-5-9-21/h2-3,6-7,10-12H,1,4-5,8-9H2,(H,27,28)(H2,23,24,25,26) QUJSOOQOQJLAAA-UHFFFAOYSA-N 660385 US20240092799, Compound XXIV-E MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660385 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660385&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086805 496708878 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390998 O=C1NC2(CCCCC2)c2cc(Nc3cc(N[C@@H]4CCCOC4)ncn3)sc12 |r| InChI=1S/C20H25N5O2S/c26-19-18-14(20(25-19)6-2-1-3-7-20)9-17(28-18)24-16-10-15(21-12-22-16)23-13-5-4-8-27-11-13/h9-10,12-13H,1-8,11H2,(H,25,26)(H2,21,22,23,24) QXGVOVDGDLVNBW-UHFFFAOYSA-N 660386 US20240092799, Compound XXIV-F MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660386 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660386&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086819 496708879 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1390999 CNC(=O)Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C17H20N6O2S/c1-18-16(25)22-12-8-11(19-9-20-12)21-13-7-10-14(26-13)15(24)23-17(10)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,23,24)(H3,18,19,20,21,22,25) HZXZPKBEGKDIRD-UHFFFAOYSA-N 660387 US20240092799, Compound XXIV-G MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660387 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660387&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086862 496708880 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391000 O=C1NC2(CCCCC2)c2cc(Nc3cc(NCC4CCCC4)ncn3)sc12 InChI=1S/C21H27N5OS/c27-20-19-15(21(26-20)8-4-1-5-9-21)10-18(28-19)25-17-11-16(23-13-24-17)22-12-14-6-2-3-7-14/h10-11,13-14H,1-9,12H2,(H,26,27)(H2,22,23,24,25) JMRXCUQSPRWHPD-UHFFFAOYSA-N 660388 US20240092799, Compound XXIV-H MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660388 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660388&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163683349 496708881 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391001 O=C(Nc1cc(Nc2cc3c(s2)C(=O)NC32CCCCC2)ncn1)C1CCOC1 InChI=1S/C20H23N5O3S/c26-18(12-4-7-28-10-12)24-15-9-14(21-11-22-15)23-16-8-13-17(29-16)19(27)25-20(13)5-2-1-3-6-20/h8-9,11-12H,1-7,10H2,(H,25,27)(H2,21,22,23,24,26) VBLRQJKWRBTYPE-UHFFFAOYSA-N 660389 US20240092799, Compound XXIV-I MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660389 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660389&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 164023402 496708882 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391002 O=C1NC2(CCCCC2)c2cc(Nc3cc(NC4CCCCC4)ncn3)sc12 InChI=1S/C21H27N5OS/c27-20-19-15(21(26-20)9-5-2-6-10-21)11-18(28-19)25-17-12-16(22-13-23-17)24-14-7-3-1-4-8-14/h11-14H,1-10H2,(H,26,27)(H2,22,23,24,25) NOHIHUDAXQVHPN-UHFFFAOYSA-N 660390 US20240092799, Compound XXIV-J MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660390 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660390&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086849 496708883 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391003 Cn1cc(Nc2cc(Nc3cc4c(s3)C(=O)NC43CCCCC3)ncn2)cn1 InChI=1S/C19H21N7OS/c1-26-10-12(9-22-26)23-14-8-15(21-11-20-14)24-16-7-13-17(28-16)18(27)25-19(13)5-3-2-4-6-19/h7-11H,2-6H2,1H3,(H,25,27)(H2,20,21,23,24) LMOUSQWUSBNOFJ-UHFFFAOYSA-N 660391 US20240092799, Compound XXIV-K MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660391 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660391&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086937 496708884 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391004 Cn1cccc(Nc2cc(Nc3cc4c(s3)C(=O)NC43CCCCC3)ncn2)c1=O InChI=1S/C21H22N6O2S/c1-27-9-5-6-14(20(27)29)24-15-11-16(23-12-22-15)25-17-10-13-18(30-17)19(28)26-21(13)7-3-2-4-8-21/h5-6,9-12H,2-4,7-8H2,1H3,(H,26,28)(H2,22,23,24,25) HLYKNCUTCDWYDK-UHFFFAOYSA-N 660392 US20240092799, Compound XXIV-L MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660392 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660392&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086893 496708885 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391005 O=C1NC2(CCCCC2)c2cc(Nc3cc(N[C@@H]4CCOC4)ncn3)sc12 |r| InChI=1S/C19H23N5O2S/c25-18-17-13(19(24-18)5-2-1-3-6-19)8-16(27-17)23-15-9-14(20-11-21-15)22-12-4-7-26-10-12/h8-9,11-12H,1-7,10H2,(H,24,25)(H2,20,21,22,23) OYSMSNUGRIEMET-UHFFFAOYSA-N 660393 US20240092799, Compound XXIV-M MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660393 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660393&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086789 496708886 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391006 CN(C)[C@H]1CCN(C1)C(=O)C1CCc2c(C1)sc1ncnc(Nc3cc4c(s3)C(=O)NC43CCCCC3)c21 |r| InChI=1S/C28H34N6O2S2/c1-33(2)17-8-11-34(14-17)27(36)16-6-7-18-20(12-16)37-26-22(18)24(29-15-30-26)31-21-13-19-23(38-21)25(35)32-28(19)9-4-3-5-10-28/h13,15-17H,3-12,14H2,1-2H3,(H,32,35)(H,29,30,31) ILDCDNJMHWRWGB-UHFFFAOYSA-N 660394 US20240092799, Compound XXV MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660394 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660394&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086912 496708887 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391007 CCOC(=O)C1CCc2c(C1)sc1ncnc(Nc3cc4c(s3)C(=O)NC43CCCCC3)c21 InChI=1S/C24H26N4O3S2/c1-2-31-23(30)13-6-7-14-16(10-13)32-22-18(14)20(25-12-26-22)27-17-11-15-19(33-17)21(29)28-24(15)8-4-3-5-9-24/h11-13H,2-10H2,1H3,(H,28,29)(H,25,26,27) VLUANTFLPZZASW-UHFFFAOYSA-N 660395 US20240092799, Compound XXV-5 MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660395 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660395&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086813 496708888 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391008 OC(=O)C1CCc2c(C1)sc1ncnc(Nc3cc4c(s3)C(=O)NC43CCCCC3)c21 InChI=1S/C22H22N4O3S2/c27-19-17-13(22(26-19)6-2-1-3-7-22)9-15(31-17)25-18-16-12-5-4-11(21(28)29)8-14(12)30-20(16)24-10-23-18/h9-11H,1-8H2,(H,26,27)(H,28,29)(H,23,24,25) IJZXWDALYZFLKG-UHFFFAOYSA-N 660396 US20240092799, Compound XXV-6 MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660396 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660396&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086889 496708889 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391009 C[C@@H]1CN(CCN1C)C(=O)C1CCc2c(C1)sc1ncnc(Nc3cc4c(s3)C(=O)NC43CCCCC3)c21 |r| InChI=1S/C28H34N6O2S2/c1-16-14-34(11-10-33(16)2)27(36)17-6-7-18-20(12-17)37-26-22(18)24(29-15-30-26)31-21-13-19-23(38-21)25(35)32-28(19)8-4-3-5-9-28/h13,15-17H,3-12,14H2,1-2H3,(H,32,35)(H,29,30,31) IVBBVBHZHXXACZ-UHFFFAOYSA-N 660397 US20240092799, Compound XXV-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660397 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660397&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163661786 496708890 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391010 CN(C)C(=O)C1CCc2c(C1)sc1ncnc(Nc3cc4c(s3)C(=O)NC43CCCCC3)c21 InChI=1S/C24H27N5O2S2/c1-29(2)23(31)13-6-7-14-16(10-13)32-22-18(14)20(25-12-26-22)27-17-11-15-19(33-17)21(30)28-24(15)8-4-3-5-9-24/h11-13H,3-10H2,1-2H3,(H,28,30)(H,25,26,27) IIJQMCSURMCOKO-UHFFFAOYSA-N 660398 US20240092799, Compound XXV-B MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660398 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660398&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086836 496708891 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391011 C[C@@H]1COCCN1C(=O)C1CCc2c(C1)sc1ncnc(Nc3cc4c(s3)C(=O)NC43CCCCC3)c21 |r| InChI=1S/C27H31N5O3S2/c1-15-13-35-10-9-32(15)26(34)16-5-6-17-19(11-16)36-25-21(17)23(28-14-29-25)30-20-12-18-22(37-20)24(33)31-27(18)7-3-2-4-8-27/h12,14-16H,2-11,13H2,1H3,(H,31,33)(H,28,29,30) KVSCXNVCGLXKHX-UHFFFAOYSA-N 660399 US20240092799, Compound XXV-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660399 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660399&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086859 496708892 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391012 O=C(C1CCc2c(C1)sc1ncnc(Nc3cc4c(s3)C(=O)NC43CCCCC3)c21)N1CCC1 InChI=1S/C25H27N5O2S2/c31-22-20-16(25(29-22)7-2-1-3-8-25)12-18(34-20)28-21-19-15-6-5-14(24(32)30-9-4-10-30)11-17(15)33-23(19)27-13-26-21/h12-14H,1-11H2,(H,29,31)(H,26,27,28) QABJKXORGPYCMX-UHFFFAOYSA-N 660400 US20240092799, Compound XXV-D MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660400 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660400&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086865 496708893 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391013 O=C1NC2(CCCCC2)c2nc(Nc3cc(N[C@H]4CCOC4)ncn3)sc12 |r| InChI=1S/C18H22N6O2S/c25-16-14-15(18(24-16)5-2-1-3-6-18)23-17(27-14)22-13-8-12(19-10-20-13)21-11-4-7-26-9-11/h8,10-11H,1-7,9H2,(H,24,25)(H2,19,20,21,22,23) PBGYUBDZOLWKSI-UHFFFAOYSA-N 660401 US20240092799, Compound XXVIII MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660401 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660401&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086768 496708894 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391014 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4[nH]ccc34)sc12 InChI=1S/C17H17N5OS/c23-16-13-11(17(22-16)5-2-1-3-6-17)8-12(24-13)21-15-10-4-7-18-14(10)19-9-20-15/h4,7-9H,1-3,5-6H2,(H,22,23)(H2,18,19,20,21) BRRFBENTOMICNT-UHFFFAOYSA-N 660338 US20240092799, Compound XVII-A::US20240092799, Compound XXVIII-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660338 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660338&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163464854 496708832 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391015 O=C1NC2(CCCCC2)c2nc(Nc3cc(Nc4ccccn4)ncn3)sc12 InChI=1S/C19H19N7OS/c27-17-15-16(19(26-17)7-3-1-4-8-19)25-18(28-15)24-14-10-13(21-11-22-14)23-12-6-2-5-9-20-12/h2,5-6,9-11H,1,3-4,7-8H2,(H,26,27)(H2,20,21,22,23,24,25) GYTIMEJTMGKLSE-UHFFFAOYSA-N 660403 US20240092799, Compound XXVIII-B MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660403 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660403&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163602394 496708895 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391016 O=C(Nc1cc(Nc2nc3c(s2)C(=O)NC32CCCCC2)ncn1)C1CCCC1 InChI=1S/C20H24N6O2S/c27-17(12-6-2-3-7-12)23-13-10-14(22-11-21-13)24-19-25-16-15(29-19)18(28)26-20(16)8-4-1-5-9-20/h10-12H,1-9H2,(H,26,28)(H2,21,22,23,24,25,27) SAYHAFVYZSCOMC-UHFFFAOYSA-N 660404 US20240092799, Compound XXVIII-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660404 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660404&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086807 496708896 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391017 O=C1NC2(CCCCC2)c2nc(Nc3cc(N[C@H]4CCCOC4)ncn3)sc12 |r| InChI=1S/C19H24N6O2S/c26-17-15-16(19(25-17)6-2-1-3-7-19)24-18(28-15)23-14-9-13(20-11-21-14)22-12-5-4-8-27-10-12/h9,11-12H,1-8,10H2,(H,25,26)(H2,20,21,22,23,24) FBMKEAREJMHZNE-UHFFFAOYSA-N 660405 US20240092799, Compound XXVIII-D MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660405 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660405&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163541521 496708897 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391018 CC1(C)COC(Nc2cc(Nc3nc4c(s3)C(=O)NC43CCCCC3)ncn2)=N1 |c:31| InChI=1S/C19H23N7O2S/c1-18(2)9-28-16(26-18)22-11-8-12(21-10-20-11)23-17-24-14-13(29-17)15(27)25-19(14)6-4-3-5-7-19/h8,10H,3-7,9H2,1-2H3,(H,25,27)(H2,20,21,22,23,24,26) JAUDUZXETRMRNY-UHFFFAOYSA-N 660406 US20240092799, Compound XXVIII-E MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660406 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660406&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086792 496708898 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391019 COc1c(N[C@H]2CCOC2)ncnc1Nc1nc2c(s1)C(=O)NC21CCCCC1 |r| InChI=1S/C19H24N6O3S/c1-27-12-15(22-11-5-8-28-9-11)20-10-21-16(12)24-18-23-14-13(29-18)17(26)25-19(14)6-3-2-4-7-19/h10-11H,2-9H2,1H3,(H,25,26)(H2,20,21,22,23,24) HOESIATXBWNRTE-UHFFFAOYSA-N 660407 US20240092799, Compound XXVIII-F MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660407 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660407&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086887 496708899 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391020 COc1c(N)ncnc1Nc1nc2c(s1)C(=O)NC21CCCCC1 InChI=1S/C15H18N6O2S/c1-23-8-11(16)17-7-18-12(8)20-14-19-10-9(24-14)13(22)21-15(10)5-3-2-4-6-15/h7H,2-6H2,1H3,(H,21,22)(H3,16,17,18,19,20) AJBXSYPNLVVSJL-UHFFFAOYSA-N 660408 US20240092799, Compound XXVIII-G MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660408 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660408&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086858 496708900 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391021 O=C1NC2(CCCCC2)c2nc(Nc3ccnc(N[C@H]4CCOC4)c3)sc12 |r| InChI=1S/C19H23N5O2S/c25-17-15-16(19(24-17)6-2-1-3-7-19)23-18(27-15)22-12-4-8-20-14(10-12)21-13-5-9-26-11-13/h4,8,10,13H,1-3,5-7,9,11H2,(H,24,25)(H2,20,21,22,23) GUOILDLVKFRAQP-UHFFFAOYSA-N 660409 US20240092799, Compound XXVIII-H MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660409 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660409&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086800 496708901 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391022 CN(C(C)=O)c1cccc(Nc2cc(Nc3nc4c(s3)C(=O)NC43CCCCC3)ncn2)c1 InChI=1S/C23H25N7O2S/c1-14(31)30(2)16-8-6-7-15(11-16)26-17-12-18(25-13-24-17)27-22-28-20-19(33-22)21(32)29-23(20)9-4-3-5-10-23/h6-8,11-13H,3-5,9-10H2,1-2H3,(H,29,32)(H2,24,25,26,27,28) YFASRQVISKJALM-UHFFFAOYSA-N 660410 US20240092799, Compound XXVIII-I MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660410 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660410&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 164120502 496708902 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391023 O=C1NC2(CCCCC2)c2nc(Nc3ccnc(Nc4ccccn4)c3)sc12 InChI=1S/C20H20N6OS/c27-18-16-17(20(26-18)8-3-1-4-9-20)25-19(28-16)23-13-7-11-22-15(12-13)24-14-6-2-5-10-21-14/h2,5-7,10-12H,1,3-4,8-9H2,(H,26,27)(H2,21,22,23,24,25) LJIGJVQEWWKRPJ-UHFFFAOYSA-N 660411 US20240092799, Compound XXVIII-J MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660411 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660411&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086818 496708903 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391024 Cn1cnc(Nc2cc(Nc3nc4c(s3)C(=O)NC43CCCCC3)ncn2)n1 InChI=1S/C17H19N9OS/c1-26-9-20-15(25-26)21-10-7-11(19-8-18-10)22-16-23-13-12(28-16)14(27)24-17(13)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,24,27)(H2,18,19,21,22,23,25) IAGJAQCEALTETN-UHFFFAOYSA-N 660412 US20240092799, Compound XXVIII-K MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660412 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660412&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086873 496708904 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391025 CNC(=O)Nc1cc(Nc2nc3c(s2)C(=O)NC32CCCCC2)ncn1 InChI=1S/C16H19N7O2S/c1-17-14(25)20-9-7-10(19-8-18-9)21-15-22-12-11(26-15)13(24)23-16(12)5-3-2-4-6-16/h7-8H,2-6H2,1H3,(H,23,24)(H3,17,18,19,20,21,22,25) POAZHDPCSIADNI-UHFFFAOYSA-N 660413 US20240092799, Compound XXVIII-L MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660413 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660413&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163874919 496708905 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391026 Cn1ccc(Nc2cc(Nc3nc4c(s3)C(=O)NC43CCCCC3)ncn2)n1 InChI=1S/C18H20N8OS/c1-26-8-5-11(25-26)21-12-9-13(20-10-19-12)22-17-23-15-14(28-17)16(27)24-18(15)6-3-2-4-7-18/h5,8-10H,2-4,6-7H2,1H3,(H,24,27)(H2,19,20,21,22,23,25) LDKIOYXOLGPKFA-UHFFFAOYSA-N 660414 US20240092799, Compound XXVIII-M MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660414&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163735716 496708906 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391027 O[C@H]1C[C@@H](C1)Nc1cc(Nc2nc3c(s2)C(=O)NC32CCCCC2)ncn1 |r,wU:3.5,wD:1.0,(-6,-5.39,;-6,-3.85,;-4.91,-2.76,;-6,-1.67,;-7.08,-2.76,;-6,-.13,;-4.66,.64,;-3.33,-.13,;-1.99,.64,;-.66,-.13,;.67,.64,;2.14,.16,;3.04,1.41,;2.14,2.66,;.67,2.18,;3.04,3.9,;2.64,5.39,;4.51,3.43,;4.51,1.89,;4.11,.4,;5.2,-.69,;6.69,-.29,;7.08,1.19,;6,2.28,;-1.99,2.18,;-3.33,2.95,;-4.66,2.18,)| InChI=1S/C18H22N6O2S/c25-11-6-10(7-11)21-12-8-13(20-9-19-12)22-17-23-15-14(27-17)16(26)24-18(15)4-2-1-3-5-18/h8-11,25H,1-7H2,(H,24,26)(H2,19,20,21,22,23) CRIWBPPXMGMARG-UHFFFAOYSA-N 660415 US20240092799, Compound XXVIII-N MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660415&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053859 496708907 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391028 O[C@H]1C[C@H](C1)Nc1cc(Nc2nc3c(s2)C(=O)NC32CCCCC2)ncn1 |r,wU:3.5,1.0,(-6,-5.39,;-6,-3.85,;-7.08,-2.76,;-6,-1.67,;-4.91,-2.76,;-6,-.13,;-4.66,.64,;-3.33,-.13,;-1.99,.64,;-.66,-.13,;.67,.64,;2.14,.16,;3.04,1.41,;2.14,2.66,;.67,2.18,;3.04,3.9,;2.64,5.39,;4.51,3.43,;4.51,1.89,;4.11,.4,;5.2,-.69,;6.69,-.29,;7.08,1.19,;6,2.28,;-1.99,2.18,;-3.33,2.95,;-4.66,2.18,)| InChI=1S/C18H22N6O2S/c25-11-6-10(7-11)21-12-8-13(20-9-19-12)22-17-23-15-14(27-17)16(26)24-18(15)4-2-1-3-5-18/h8-11,25H,1-7H2,(H,24,26)(H2,19,20,21,22,23) CRIWBPPXMGMARG-UHFFFAOYSA-N 660416 US20240092799, Compound XXVIII-O MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660416&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053859 496708908 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391029 CN(C(C)=O)c1ccnc(Nc2cc(Nc3nc4c(s3)C(=O)NC43CCCCC3)ncn2)c1 InChI=1S/C22H24N8O2S/c1-13(31)30(2)14-6-9-23-15(10-14)26-16-11-17(25-12-24-16)27-21-28-19-18(33-21)20(32)29-22(19)7-4-3-5-8-22/h6,9-12H,3-5,7-8H2,1-2H3,(H,29,32)(H2,23,24,25,26,27,28) ZYCYBXWWDDPBBW-UHFFFAOYSA-N 660417 US20240092799, Compound XXVIII-P MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660417&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086895 496708909 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391030 O=C1NC2(CCCCC2)c2nc(Nc3cc(Nc4ccc(cn4)N4CCOCC4)ncn3)sc12 InChI=1S/C23H26N8O2S/c32-21-19-20(23(30-21)6-2-1-3-7-23)29-22(34-19)28-18-12-17(25-14-26-18)27-16-5-4-15(13-24-16)31-8-10-33-11-9-31/h4-5,12-14H,1-3,6-11H2,(H,30,32)(H2,24,25,26,27,28,29) NJHWYNUNQROXPI-UHFFFAOYSA-N 660418 US20240092799, Compound XXVIII-Q MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660418&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053838 496708910 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391031 CN1CCN(CC1)c1ccc(Nc2cc(Nc3nc4c(s3)C(=O)NC43CCCCC3)ncn2)nc1 InChI=1S/C24H29N9OS/c1-32-9-11-33(12-10-32)16-5-6-17(25-14-16)28-18-13-19(27-15-26-18)29-23-30-21-20(35-23)22(34)31-24(21)7-3-2-4-8-24/h5-6,13-15H,2-4,7-12H2,1H3,(H,31,34)(H2,25,26,27,28,29,30) ZZXVHERNWDMDLE-UHFFFAOYSA-N 660419 US20240092799, Compound XXVIII-R MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660419&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086894 496708911 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391032 Cc1cc(Nc2cc(N)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C17H20N6O2/c1-10-7-13(21-12-8-11(18)19-9-20-12)23(25)15-14(10)16(24)22-17(15)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H3,18,19,20,21) RQRJJHJUBAWMGS-UHFFFAOYSA-N 660420 US20240092799, Compound XXIX MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660420&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086864 496708912 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391033 Cc3cc(Nc2cc(N[C@H]1CCOC1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C21H26N6O3/c1-13-9-17(25-16-10-15(22-12-23-16)24-14-5-8-30-11-14)27(29)19-18(13)20(28)26-21(19)6-3-2-4-7-21/h9-10,12,14H,2-8,11H2,1H3,(H,26,28)(H2,22,23,24,25) ZKIZZDJMIPAICX-UHFFFAOYSA-N 660421 US20240092799, Compound XXIX-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660421&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086910 496708913 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391034 COCCNc4cc(Nc3cc(C)c2C(=O)NC1(CCCCC1)c2[n+]3[O-])ncn4 InChI=1S/C20H26N6O3/c1-13-10-16(24-15-11-14(22-12-23-15)21-8-9-29-2)26(28)18-17(13)19(27)25-20(18)6-4-3-5-7-20/h10-12H,3-9H2,1-2H3,(H,25,27)(H2,21,22,23,24) HMUHEKLHIOMMMA-UHFFFAOYSA-N 660422 US20240092799, Compound XXIX-B MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660422&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086843 496708914 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391035 COCCCNc4cc(Nc3cc(C)c2C(=O)NC1(CCCCC1)c2[n+]3[O-])ncn4 InChI=1S/C21H28N6O3/c1-14-11-17(25-16-12-15(23-13-24-16)22-9-6-10-30-2)27(29)19-18(14)20(28)26-21(19)7-4-3-5-8-21/h11-13H,3-10H2,1-2H3,(H,26,28)(H2,22,23,24,25) VTULASJDFLSKFK-UHFFFAOYSA-N 660423 US20240092799, Compound XXIX-C MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660423&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086787 496708915 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391036 Cc3cc(Nc2cc(Nc1ccccn1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H23N7O2/c1-14-11-18(27-17-12-16(24-13-25-17)26-15-7-3-6-10-23-15)29(31)20-19(14)21(30)28-22(20)8-4-2-5-9-22/h3,6-7,10-13H,2,4-5,8-9H2,1H3,(H,28,30)(H2,23,24,25,26,27) ZBSIZCILWFDMMG-UHFFFAOYSA-N 660424 US20240092799, Compound XXIX-AN::US20240092799, Compound XXIX-D MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660424&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086778 496708916 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391037 Cc3cc(Nc2cc(N[C@H]1CCCOC1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H28N6O3/c1-14-10-18(26-17-11-16(23-13-24-17)25-15-6-5-9-31-12-15)28(30)20-19(14)21(29)27-22(20)7-3-2-4-8-22/h10-11,13,15H,2-9,12H2,1H3,(H,27,29)(H2,23,24,25,26) GUCONBFPKFADBW-UHFFFAOYSA-N 660425 US20240092799, Compound XXIX-E MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660425&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086852 496708917 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391038 Cc3cc(Nc1ncnc2[nH]ccc12)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C19H20N6O2/c1-11-9-13(23-17-12-5-8-20-16(12)21-10-22-17)25(27)15-14(11)18(26)24-19(15)6-3-2-4-7-19/h5,8-10H,2-4,6-7H2,1H3,(H,24,26)(H2,20,21,22,23) MZHCDEKVMZHWAN-UHFFFAOYSA-N 660426 US20240092799, Compound XXIX-F MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660426&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086882 496708918 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391039 Cc3cc(Nc2cc(NC(=O)C1CCCC1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C23H28N6O3/c1-14-11-18(29(32)20-19(14)22(31)28-23(20)9-5-2-6-10-23)26-16-12-17(25-13-24-16)27-21(30)15-7-3-4-8-15/h11-13,15H,2-10H2,1H3,(H,28,31)(H2,24,25,26,27,30) DEFFQGWDYXNYKB-UHFFFAOYSA-N 660427 US20240092799, Compound XXIX-G MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660427 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660427&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053862 496708919 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391040 Cc3cc(Nc2ccnc(N[C@H]1CCOC1)c2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H27N5O3/c1-14-11-18(25-15-5-9-23-17(12-15)24-16-6-10-30-13-16)27(29)20-19(14)21(28)26-22(20)7-3-2-4-8-22/h5,9,11-12,16H,2-4,6-8,10,13H2,1H3,(H,26,28)(H2,23,24,25) VJHYJZYCPNPBEO-UHFFFAOYSA-N 660428 US20240092799, Compound XXIX-H MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660428 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660428&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086883 496708920 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391041 Cc2cc(Nc1cc(NCCO)ncn1)[n+]([O-])c3c2C(=O)NC34CCCCC4 InChI=1S/C19H24N6O3/c1-12-9-15(23-14-10-13(20-7-8-26)21-11-22-14)25(28)17-16(12)18(27)24-19(17)5-3-2-4-6-19/h9-11,26H,2-8H2,1H3,(H,24,27)(H2,20,21,22,23) QUXVEFBNCHYREZ-UHFFFAOYSA-N 660429 US20240092799, Compound XXIX-I MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660429 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660429&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086817 496708921 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391042 CC(=O)N5CC[C@H](Nc4cc(Nc3cc(C)c2C(=O)NC1(CCCCC1)c2[n+]3[O-])ncn4)C5 InChI=1S/C23H29N7O3/c1-14-10-19(30(33)21-20(14)22(32)28-23(21)7-4-3-5-8-23)27-18-11-17(24-13-25-18)26-16-6-9-29(12-16)15(2)31/h10-11,13,16H,3-9,12H2,1-2H3,(H,28,32)(H2,24,25,26,27) BOZIPOWJVGLTMQ-UHFFFAOYSA-N 660430 US20240092799, Compound XXIX-J MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660430 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660430&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053852 496708922 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391043 Cc3cc(Nc2cc(Nc1ccn(C)n1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C21H24N8O2/c1-13-10-17(25-16-11-15(22-12-23-16)24-14-6-9-28(2)27-14)29(31)19-18(13)20(30)26-21(19)7-4-3-5-8-21/h6,9-12H,3-5,7-8H2,1-2H3,(H,26,30)(H2,22,23,24,25,27) APAGGKVURBBOEV-UHFFFAOYSA-N 660431 US20240092799, Compound XXIX-K MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660431&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086786 496708923 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391044 Cc3cc(Nc2cc(NC1CCCC1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H28N6O2/c1-14-11-18(26-17-12-16(23-13-24-17)25-15-7-3-4-8-15)28(30)20-19(14)21(29)27-22(20)9-5-2-6-10-22/h11-13,15H,2-10H2,1H3,(H,27,29)(H2,23,24,25,26) CDLYNCVICQQRSE-UHFFFAOYSA-N 660432 US20240092799, Compound XXIX-L MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660432&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086770 496708924 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391045 Cc3cc(Nc2cc(NC1=NC(C)(C)CO1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H27N7O3/c1-13-9-16(29(31)18-17(13)19(30)27-22(18)7-5-4-6-8-22)25-14-10-15(24-12-23-14)26-20-28-21(2,3)11-32-20/h9-10,12H,4-8,11H2,1-3H3,(H,27,30)(H2,23,24,25,26,28) NJCSCBQGGAPUSS-UHFFFAOYSA-N 660433 US20240092799, Compound XXIX-M MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660433 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660433&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086911 496708925 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391046 CN(C(C)=O)c1cccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)c1 InChI=1S/C26H29N7O3/c1-16-12-22(33(36)24-23(16)25(35)31-26(24)10-5-4-6-11-26)30-21-14-20(27-15-28-21)29-18-8-7-9-19(13-18)32(3)17(2)34/h7-9,12-15H,4-6,10-11H2,1-3H3,(H,31,35)(H2,27,28,29,30) JRJQSQSAPUSJTB-UHFFFAOYSA-N 660434 US20240092799, Compound XXIX-N MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660434&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086867 496708926 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391047 Cc1cc(Nc2ncnc3[nH]cnc23)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C18H19N7O2/c1-10-7-11(23-16-13-15(20-8-19-13)21-9-22-16)25(27)14-12(10)17(26)24-18(14)5-3-2-4-6-18/h7-9H,2-6H2,1H3,(H,24,26)(H2,19,20,21,22,23) FGJVTYJLFKOGHL-UHFFFAOYSA-N 660435 US20240092799, Compound XXIX-O MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660435 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660435&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163547605 496708927 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391048 Cc1cc(Nc2cc(NCC3CCCO3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C22H28N6O3/c1-14-10-18(26-17-11-16(24-13-25-17)23-12-15-6-5-9-31-15)28(30)20-19(14)21(29)27-22(20)7-3-2-4-8-22/h10-11,13,15H,2-9,12H2,1H3,(H,27,29)(H2,23,24,25,26) HFEMNLPOHIMERI-UHFFFAOYSA-N 660436 US20240092799, Compound XXIX-P MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660436&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086810 496708928 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391049 Cc1cc(Nc2cc(NC3CNC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C20H25N7O2/c1-12-7-16(25-15-8-14(22-11-23-15)24-13-9-21-10-13)27(29)18-17(12)19(28)26-20(18)5-3-2-4-6-20/h7-8,11,13,21H,2-6,9-10H2,1H3,(H,26,28)(H2,22,23,24,25) LHTLHEPGCBTMJS-UHFFFAOYSA-N 660437 US20240092799, Compound XXIX-Q MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660437&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086785 496708929 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391050 Cc1cc(Nc2cc(NC3CCOCC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C22H28N6O3/c1-14-11-18(26-17-12-16(23-13-24-17)25-15-5-9-31-10-6-15)28(30)20-19(14)21(29)27-22(20)7-3-2-4-8-22/h11-13,15H,2-10H2,1H3,(H,27,29)(H2,23,24,25,26) JEMIQKQBQMSNTP-UHFFFAOYSA-N 660438 US20240092799, Compound XXIX-R MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660438&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086838 496708930 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391051 Cc1cc(Nc2cc(N[C@H]3CCNC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |r| InChI=1S/C21H27N7O2/c1-13-9-17(26-16-10-15(23-12-24-16)25-14-5-8-22-11-14)28(30)19-18(13)20(29)27-21(19)6-3-2-4-7-21/h9-10,12,14,22H,2-8,11H2,1H3,(H,27,29)(H2,23,24,25,26) VSCMCABFEXVSPG-UHFFFAOYSA-N 660439 US20240092799, Compound XXIX-S MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660439&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086820 496708931 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391052 Cc1cc(Nc2cc(N[C@H]3C[C@H](O)C3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |r,wU:9.8,wD:11.11,(2.2,4.94,;2.2,3.4,;.87,2.63,;.87,1.09,;-.46,.32,;-1.8,1.09,;-3.13,.32,;-4.47,1.09,;-5.8,.32,;-5.8,-1.22,;-4.71,-2.31,;-5.8,-3.4,;-5.8,-4.94,;-6.89,-2.31,;-4.47,2.63,;-3.13,3.4,;-1.8,2.63,;2.2,.32,;2.2,-1.22,;3.54,1.09,;3.54,2.63,;5,3.1,;5.48,4.57,;5.91,1.86,;5,.61,;3.91,-.48,;4.31,-1.96,;5.8,-2.36,;6.89,-1.27,;6.49,.21,)| InChI=1S/C21H26N6O3/c1-12-7-17(25-16-10-15(22-11-23-16)24-13-8-14(28)9-13)27(30)19-18(12)20(29)26-21(19)5-3-2-4-6-21/h7,10-11,13-14,28H,2-6,8-9H2,1H3,(H,26,29)(H2,22,23,24,25) CMUMLSVYYYERKD-UHFFFAOYSA-N 660440 US20240092799, Compound XXIX-T MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660440&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053855 496708932 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391053 CN(C)C(=O)Nc1cc(Nc2cc(C)c3C(=O)NC4(CCCCC4)c3[n+]2[O-])ncn1 InChI=1S/C20H25N7O3/c1-12-9-15(23-13-10-14(22-11-21-13)24-19(29)26(2)3)27(30)17-16(12)18(28)25-20(17)7-5-4-6-8-20/h9-11H,4-8H2,1-3H3,(H,25,28)(H2,21,22,23,24,29) SXWFDDSJHIZCTH-UHFFFAOYSA-N 660441 US20240092799, Compound XXIX-U MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660441&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163980400 496708933 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391054 Cc1cc(Nc2cc(N[C@H]3CCC[C@@H]3O)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |r| InChI=1S/C22H28N6O3/c1-13-10-18(26-17-11-16(23-12-24-17)25-14-6-5-7-15(14)29)28(31)20-19(13)21(30)27-22(20)8-3-2-4-9-22/h10-12,14-15,29H,2-9H2,1H3,(H,27,30)(H2,23,24,25,26) PQYZYTKWJNFYSZ-UHFFFAOYSA-N 660442 US20240092799, Compound XXIX-V MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660442 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660442&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086857 496708934 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391055 Cc1cc(Nc2cc(N[C@@H]3CCC[C@@H]3O)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |r| InChI=1S/C22H28N6O3/c1-13-10-18(26-17-11-16(23-12-24-17)25-14-6-5-7-15(14)29)28(31)20-19(13)21(30)27-22(20)8-3-2-4-9-22/h10-12,14-15,29H,2-9H2,1H3,(H,27,30)(H2,23,24,25,26) PQYZYTKWJNFYSZ-UHFFFAOYSA-N 660443 US20240092799, Compound XXIX-W MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660443&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086919 496708935 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391056 Cc1cc(Nc2cc(N[C@@H]3CCC[C@H]3O)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |r| InChI=1S/C22H28N6O3/c1-13-10-18(26-17-11-16(23-12-24-17)25-14-6-5-7-15(14)29)28(31)20-19(13)21(30)27-22(20)8-3-2-4-9-22/h10-12,14-15,29H,2-9H2,1H3,(H,27,30)(H2,23,24,25,26) PQYZYTKWJNFYSZ-UHFFFAOYSA-N 660444 US20240092799, Compound XXIX-X MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660444&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086888 496708936 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391057 Cc1cc(Nc2cc(N[C@H]3CC[C@@H](O)C3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |r| InChI=1S/C22H28N6O3/c1-13-9-18(26-17-11-16(23-12-24-17)25-14-5-6-15(29)10-14)28(31)20-19(13)21(30)27-22(20)7-3-2-4-8-22/h9,11-12,14-15,29H,2-8,10H2,1H3,(H,27,30)(H2,23,24,25,26) OGJQPSPPRQKOKT-UHFFFAOYSA-N 660445 US20240092799, Compound XXIX-Y MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660445&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086840 496708937 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391058 COc1c(N)ncnc1Nc1cc(C)c2C(=O)NC3(CCCCC3)c2[n+]1[O-] InChI=1S/C18H22N6O3/c1-10-8-11(22-16-13(27-2)15(19)20-9-21-16)24(26)14-12(10)17(25)23-18(14)6-4-3-5-7-18/h8-9H,3-7H2,1-2H3,(H,23,25)(H3,19,20,21,22) RYJMOUHCCJFELS-UHFFFAOYSA-N 660446 US20240092799, Compound XXIX-Z MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660446&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163949869 496708938 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391059 CN(C(C)=O)c1cccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)n1 InChI=1S/C25H28N8O3/c1-15-12-21(33(36)23-22(15)24(35)31-25(23)10-5-4-6-11-25)30-19-13-18(26-14-27-19)28-17-8-7-9-20(29-17)32(3)16(2)34/h7-9,12-14H,4-6,10-11H2,1-3H3,(H,31,35)(H2,26,27,28,29,30) PIEVCKCSJMWFNK-UHFFFAOYSA-N 660447 US20240092799, Compound XXIX-AA MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660447 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660447&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086923 496708939 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391060 Cc1cc(Nc2ncnc3NCCc23)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C19H22N6O2/c1-11-9-13(23-17-12-5-8-20-16(12)21-10-22-17)25(27)15-14(11)18(26)24-19(15)6-3-2-4-7-19/h9-10H,2-8H2,1H3,(H,24,26)(H2,20,21,22,23) RLTXKMCSZRSQDB-UHFFFAOYSA-N 660448 US20240092799, Compound XXIX-AB MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660448&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086801 496708940 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391061 CC(=O)N5CC(Nc4cc(Nc3cc(C)c2C(=O)NC1(CCCCC1)c2[n+]3[O-])ncn4)C5 InChI=1S/C22H27N7O3/c1-13-8-18(29(32)20-19(13)21(31)27-22(20)6-4-3-5-7-22)26-17-9-16(23-12-24-17)25-15-10-28(11-15)14(2)30/h8-9,12,15H,3-7,10-11H2,1-2H3,(H,27,31)(H2,23,24,25,26) BAORJWLCLUHOTF-UHFFFAOYSA-N 660449 US20240092799, Compound XXIX-AC MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660449&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086870 496708941 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391062 Cc3cc(Nc2cc(Nc1ncn(C)n1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C20H23N9O2/c1-12-8-15(24-13-9-14(22-10-21-13)25-19-23-11-28(2)27-19)29(31)17-16(12)18(30)26-20(17)6-4-3-5-7-20/h8-11H,3-7H2,1-2H3,(H,26,30)(H2,21,22,24,25,27) MHEMKJCIJOVNBB-UHFFFAOYSA-N 660450 US20240092799, Compound XXIX-AD MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660450 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660450&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086821 496708942 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391063 Cc3cc(Nc2cc(N[C@@H]1COC[C@H]1O)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C21H26N6O4/c1-12-7-17(25-16-8-15(22-11-23-16)24-13-9-31-10-14(13)28)27(30)19-18(12)20(29)26-21(19)5-3-2-4-6-21/h7-8,11,13-14,28H,2-6,9-10H2,1H3,(H,26,29)(H2,22,23,24,25) FKNLKMFMXNSTFG-UHFFFAOYSA-N 660451 US20240092799, Compound XXIX-AE MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660451 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660451&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163552878 496708943 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391064 Cc3cc(Nc2cc(Nc1ccn(F)n1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C20H21FN8O2/c1-12-9-16(25-15-10-14(22-11-23-15)24-13-5-8-28(21)27-13)29(31)18-17(12)19(30)26-20(18)6-3-2-4-7-20/h5,8-11H,2-4,6-7H2,1H3,(H,26,30)(H2,22,23,24,25,27) LSDFHFGCQOLDED-UHFFFAOYSA-N 660452 US20240092799, Compound XXIX-AF MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660452 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660452&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053881 496708944 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391065 COc1c(N[C@H]2CCOC2)ncnc1Nc1cc(C)c2C(=O)NC3(CCCCC3)c2[n+]1O |r| InChI=1S/C22H28N6O4/c1-13-10-15(28(30)18-16(13)21(29)27-22(18)7-4-3-5-8-22)26-20-17(31-2)19(23-12-24-20)25-14-6-9-32-11-14/h10,12,14,30H,3-9,11H2,1-2H3,(H2,23,24,25,27,29)/p+1 LNDPJJQMIHBGEH-UHFFFAOYSA-O 660453 US20240092799, Compound XXIX-AG MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660453 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660453&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053868 496708945 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391066 Cc3cc(Nc2cc(Nc1ccccc1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C23H24N6O2/c1-15-12-19(27-18-13-17(24-14-25-18)26-16-8-4-2-5-9-16)29(31)21-20(15)22(30)28-23(21)10-6-3-7-11-23/h2,4-5,8-9,12-14H,3,6-7,10-11H2,1H3,(H,28,30)(H2,24,25,26,27) ZRGGAJBNTOCWPC-UHFFFAOYSA-N 660454 US20240092799, Compound XXIX-AH MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660454 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660454&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086854 496708946 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391067 Cc1cc(Nc2cc(Nc3ccccc3F)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C23H23FN6O2/c1-14-11-19(30(32)21-20(14)22(31)29-23(21)9-5-2-6-10-23)28-18-12-17(25-13-26-18)27-16-8-4-3-7-15(16)24/h3-4,7-8,11-13H,2,5-6,9-10H2,1H3,(H,29,31)(H2,25,26,27,28) NWVWYGGMSFREMH-UHFFFAOYSA-N 660455 US20240092799, Compound XXIX-AI MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660455 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660455&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086920 496708947 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391068 Cc1cc(Nc2cc(Nc3cccnc3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C22H23N7O2/c1-14-10-18(27-17-11-16(24-13-25-17)26-15-6-5-9-23-12-15)29(31)20-19(14)21(30)28-22(20)7-3-2-4-8-22/h5-6,9-13H,2-4,7-8H2,1H3,(H,28,30)(H2,24,25,26,27) OBMYRENMELOJDW-UHFFFAOYSA-N 660456 US20240092799, Compound XXIX-AJ MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660456 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660456&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086837 496708948 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391069 Cc1cc(Nc2cc(Nc3ccncc3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C22H23N7O2/c1-14-11-18(27-17-12-16(24-13-25-17)26-15-5-9-23-10-6-15)29(31)20-19(14)21(30)28-22(20)7-3-2-4-8-22/h5-6,9-13H,2-4,7-8H2,1H3,(H,28,30)(H2,23,24,25,26,27) LDHMHXOTEGEFCD-UHFFFAOYSA-N 660457 US20240092799, Compound XXIX-AK MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660457 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660457&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086775 496708949 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391070 Cc1cccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)n1 InChI=1S/C23H25N7O2/c1-14-11-19(30(32)21-20(14)22(31)29-23(21)9-4-3-5-10-23)28-18-12-17(24-13-25-18)27-16-8-6-7-15(2)26-16/h6-8,11-13H,3-5,9-10H2,1-2H3,(H,29,31)(H2,24,25,26,27,28) BPBDMKZLUVFDAS-UHFFFAOYSA-N 660458 US20240092799, Compound XXIX-AL MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660458 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660458&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086799 496708950 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391071 Cc3cc(Nc2cc(Nc1ncc(F)cc1F)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H21F2N7O2/c1-12-7-17(31(33)19-18(12)21(32)30-22(19)5-3-2-4-6-22)28-15-9-16(27-11-26-15)29-20-14(24)8-13(23)10-25-20/h7-11H,2-6H2,1H3,(H,30,32)(H2,25,26,27,28,29) CDEGWRYVTGWORF-UHFFFAOYSA-N 660459 US20240092799, Compound XXIX-AM MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660459&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163479349 496708951 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391072 Cc3cc(Nc2cc(Nc1ccccn1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H23N7O2/c1-14-11-18(27-17-12-16(24-13-25-17)26-15-7-3-6-10-23-15)29(31)20-19(14)21(30)28-22(20)8-4-2-5-9-22/h3,6-7,10-13H,2,4-5,8-9H2,1H3,(H,28,30)(H2,23,24,25,26,27) ZBSIZCILWFDMMG-UHFFFAOYSA-N 660424 US20240092799, Compound XXIX-AN::US20240092799, Compound XXIX-D MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens >1000 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660424&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086778 496708916 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391073 CN1CCN(CC1)c1ccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)nc1 InChI=1S/C27H33N9O2/c1-18-14-23(36(38)25-24(18)26(37)33-27(25)8-4-3-5-9-27)32-22-15-21(29-17-30-22)31-20-7-6-19(16-28-20)35-12-10-34(2)11-13-35/h6-7,14-17H,3-5,8-13H2,1-2H3,(H,33,37)(H2,28,29,30,31,32) BLABQPYFQZAHPI-UHFFFAOYSA-N 660461 US20240092799, Compound XXIX-AO MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660461 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660461&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086835 496708952 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391074 Cc3cc(Nc2cc(N[C@H]1C[C@@H](O)C1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C21H26N6O3/c1-12-7-17(25-16-10-15(22-11-23-16)24-13-8-14(28)9-13)27(30)19-18(12)20(29)26-21(19)5-3-2-4-6-21/h7,10-11,13-14,28H,2-6,8-9H2,1H3,(H,26,29)(H2,22,23,24,25) CMUMLSVYYYERKD-UHFFFAOYSA-N 660462 US20240092799, Compound XXIX-AP MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660462 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660462&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053855 496708953 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391075 Cc3cc(Nc2cc(NC(=O)N1CCCC1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H27N7O3/c1-14-11-17(29(32)19-18(14)20(30)27-22(19)7-3-2-4-8-22)25-15-12-16(24-13-23-15)26-21(31)28-9-5-6-10-28/h11-13H,2-10H2,1H3,(H,27,30)(H2,23,24,25,26,31) BWEYIMHVBGIVAM-UHFFFAOYSA-N 660463 US20240092799, Compound XXIX-AQ MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660463 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660463&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053887 496708954 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391076 Cc3cc(Nc2cc(NC1CCS(=O)(=O)C1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C21H26N6O4S/c1-13-9-17(27(29)19-18(13)20(28)26-21(19)6-3-2-4-7-21)25-16-10-15(22-12-23-16)24-14-5-8-32(30,31)11-14/h9-10,12,14H,2-8,11H2,1H3,(H,26,28)(H2,22,23,24,25) XRHORPDIGUEAED-UHFFFAOYSA-N 660464 US20240092799, Compound XXIX-AR MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660464 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660464&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 164104189 496708955 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391077 Cc3cc(Nc2cc(Nc1cc[nH]n1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C20H22N8O2/c1-12-9-16(25-15-10-14(21-11-22-15)24-13-5-8-23-27-13)28(30)18-17(12)19(29)26-20(18)6-3-2-4-7-20/h5,8-11H,2-4,6-7H2,1H3,(H,26,29)(H3,21,22,23,24,25,27) OCRCLDDWPKYYFW-UHFFFAOYSA-N 660465 US20240092799, Compound XXIX-AS MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660465 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660465&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086917 496708956 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391078 Cc3cc(Nc2cc(Nc1ccn(CCO)n1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H26N8O3/c1-14-11-18(30(33)20-19(14)21(32)27-22(20)6-3-2-4-7-22)26-17-12-16(23-13-24-17)25-15-5-8-29(28-15)9-10-31/h5,8,11-13,31H,2-4,6-7,9-10H2,1H3,(H,27,32)(H2,23,24,25,26,28) ASKCWTIXWMRKTM-UHFFFAOYSA-N 660466 US20240092799, Compound XXIX-AT MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660466 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660466&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086776 496708957 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391079 Cc3cc(Nc2cc(Nc1cccc(CO)n1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C23H25N7O3/c1-14-10-19(30(33)21-20(14)22(32)29-23(21)8-3-2-4-9-23)28-18-11-17(24-13-25-18)27-16-7-5-6-15(12-31)26-16/h5-7,10-11,13,31H,2-4,8-9,12H2,1H3,(H,29,32)(H2,24,25,26,27,28) OEIIPBZUTXWBBB-UHFFFAOYSA-N 660467 US20240092799, Compound XXIX-AU MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660467 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660467&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163831931 496708958 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391080 Cc1cc(Nc2cc(NCC3CCOC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C22H28N6O3/c1-14-9-18(26-17-10-16(24-13-25-17)23-11-15-5-8-31-12-15)28(30)20-19(14)21(29)27-22(20)6-3-2-4-7-22/h9-10,13,15H,2-8,11-12H2,1H3,(H,27,29)(H2,23,24,25,26) POGVOHZRGIXILR-UHFFFAOYSA-N 660468 US20240092799, Compound XXIX-AV MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660468 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660468&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086927 496708959 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391081 Cc1cc(Nc2cc(NC(=O)C3CCCO3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C22H26N6O4/c1-13-10-17(28(31)19-18(13)21(30)27-22(19)7-3-2-4-8-22)25-15-11-16(24-12-23-15)26-20(29)14-6-5-9-32-14/h10-12,14H,2-9H2,1H3,(H,27,30)(H2,23,24,25,26,29) JSAVIGJYZCHHAC-UHFFFAOYSA-N 660469 US20240092799, Compound XXIX-AW MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660469 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660469&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053861 496708960 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391082 Cc1cc(Nc2cc(N[C@@H]3CCOC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |r| InChI=1S/C21H26N6O3/c1-13-9-17(25-16-10-15(22-12-23-16)24-14-5-8-30-11-14)27(29)19-18(13)20(28)26-21(19)6-3-2-4-7-21/h9-10,12,14H,2-8,11H2,1H3,(H,26,28)(H2,22,23,24,25) ZKIZZDJMIPAICX-UHFFFAOYSA-N 660470 US20240092799, Compound XXIX-AX MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660470 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660470&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086811 496708961 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391083 Cc1cc(Nc2cc(N[C@H]3CCOC3)nc(C)n2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |r| InChI=1S/C22H28N6O3/c1-13-10-18(26-17-11-16(23-14(2)24-17)25-15-6-9-31-12-15)28(30)20-19(13)21(29)27-22(20)7-4-3-5-8-22/h10-11,15H,3-9,12H2,1-2H3,(H,27,29)(H2,23,24,25,26) RXQUHQAIRRFDJZ-UHFFFAOYSA-N 660471 US20240092799, Compound XXIX-AY MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660471 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660471&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086842 496708962 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391084 Cc1cc(Nc2cc(Nc3ncccc3C)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C23H25N7O2/c1-14-7-6-10-24-21(14)28-17-12-16(25-13-26-17)27-18-11-15(2)19-20(30(18)32)23(29-22(19)31)8-4-3-5-9-23/h6-7,10-13H,3-5,8-9H2,1-2H3,(H,29,31)(H2,24,25,26,27,28) SMDQASWFWNCTQL-UHFFFAOYSA-N 660472 US20240092799, Compound XXIX-AZ MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660472&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086760 496708963 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391085 Cc1ccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)nc1 InChI=1S/C23H25N7O2/c1-14-6-7-16(24-12-14)27-17-11-18(26-13-25-17)28-19-10-15(2)20-21(30(19)32)23(29-22(20)31)8-4-3-5-9-23/h6-7,10-13H,3-5,8-9H2,1-2H3,(H,29,31)(H2,24,25,26,27,28) YMNOARXFOWTBJS-UHFFFAOYSA-N 660473 US20240092799, Compound XXIX-AAA MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660473 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660473&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086851 496708964 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391086 Cc1nc(Nc2ccccn2)cc(Nc2cc(C)c3C(=O)NC4(CCCCC4)c3[n+]2[O-])n1 InChI=1S/C23H25N7O2/c1-14-12-19(30(32)21-20(14)22(31)29-23(21)9-5-3-6-10-23)28-18-13-17(25-15(2)26-18)27-16-8-4-7-11-24-16/h4,7-8,11-13H,3,5-6,9-10H2,1-2H3,(H,29,31)(H2,24,25,26,27,28) WQDGTEMTUBQJSY-UHFFFAOYSA-N 660474 US20240092799, Compound XXIX-AAB MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660474 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660474&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086909 496708965 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391087 Cc3cc(Nc2cc(N[C@@H]1C[C@](C)(O)C1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C22H28N6O3/c1-13-8-17(26-16-9-15(23-12-24-16)25-14-10-21(2,30)11-14)28(31)19-18(13)20(29)27-22(19)6-4-3-5-7-22/h8-9,12,14,30H,3-7,10-11H2,1-2H3,(H,27,29)(H2,23,24,25,26) RRKHXNLMXJKYAQ-UHFFFAOYSA-N 660475 US20240092799, Compound XXIX-AAC MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660475 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660475&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053885 496708966 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391088 Cc3cc(Nc2cc(Nc1ccon1)ncn2)[n+]([O-])c4c3C(=O)NC45CCCCC5 InChI=1S/C20H21N7O3/c1-12-9-16(24-15-10-14(21-11-22-15)23-13-5-8-30-26-13)27(29)18-17(12)19(28)25-20(18)6-3-2-4-7-20/h5,8-11H,2-4,6-7H2,1H3,(H,25,28)(H2,21,22,23,24,26) FMARPEAHTMOJES-UHFFFAOYSA-N 660476 US20240092799, Compound XXIX-AAD MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660476 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660476&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086929 496708967 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391089 CO[C@H]5C[C@@H](Nc4cc(Nc3cc(C)c2C(=O)NC1(CCCCC1)c2[n+]3[O-])ncn4)C5 InChI=1S/C22H28N6O3/c1-13-8-18(26-17-11-16(23-12-24-17)25-14-9-15(10-14)31-2)28(30)20-19(13)21(29)27-22(20)6-4-3-5-7-22/h8,11-12,14-15H,3-7,9-10H2,1-2H3,(H,27,29)(H2,23,24,25,26) UYHHUEQVHWFTKX-UHFFFAOYSA-N 660477 US20240092799, Compound XXIX-AAE MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660477 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660477&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086905 496708968 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391090 Cc1cc(Nc2cc(NC(=O)c3ccccn3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C23H23N7O3/c1-14-11-18(30(33)20-19(14)22(32)29-23(20)8-4-2-5-9-23)27-16-12-17(26-13-25-16)28-21(31)15-7-3-6-10-24-15/h3,6-7,10-13H,2,4-5,8-9H2,1H3,(H,29,32)(H2,25,26,27,28,31) QKUPOCJHZJOCPW-UHFFFAOYSA-N 660478 US20240092799, Compound XXIX-AAF MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660478 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660478&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086861 496708969 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391091 COC(=O)C1(CCOC1)Nc1cc(Nc2cc(C)c3C(=O)NC4(CCCCC4)c3[n+]2[O-])ncn1 InChI=1S/C23H28N6O5/c1-14-10-17(29(32)19-18(14)20(30)28-22(19)6-4-3-5-7-22)26-15-11-16(25-13-24-15)27-23(21(31)33-2)8-9-34-12-23/h10-11,13H,3-9,12H2,1-2H3,(H,28,30)(H2,24,25,26,27) GICJPNRYCYHYMP-UHFFFAOYSA-N 660479 US20240092799, Compound XXIX-AAG MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 550 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660479 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660479&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086871 496708970 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391092 Cc1cc(Nc2ncnc3[nH]ncc23)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C18H19N7O2/c1-10-7-12(22-15-11-8-21-24-16(11)20-9-19-15)25(27)14-13(10)17(26)23-18(14)5-3-2-4-6-18/h7-9H,2-6H2,1H3,(H,23,26)(H2,19,20,21,22,24) FBKYNKBJAOEUGT-UHFFFAOYSA-N 660480 US20240092799, Compound XXIX-AAH MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660480 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660480&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086822 496708971 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391093 Cc1ccnc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)c1 InChI=1S/C23H25N7O2/c1-14-6-9-24-16(10-14)27-17-12-18(26-13-25-17)28-19-11-15(2)20-21(30(19)32)23(29-22(20)31)7-4-3-5-8-23/h6,9-13H,3-5,7-8H2,1-2H3,(H,29,31)(H2,24,25,26,27,28) LVBYAVBVMHBZCV-UHFFFAOYSA-N 660481 US20240092799, Compound XXIX-AAI MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660481 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660481&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086761 496708972 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391094 Cc1cc(Nc2cc(Nc3ccc(cn3)N3CCOCC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C26H30N8O3/c1-17-13-22(34(36)24-23(17)25(35)32-26(24)7-3-2-4-8-26)31-21-14-20(28-16-29-21)30-19-6-5-18(15-27-19)33-9-11-37-12-10-33/h5-6,13-16H,2-4,7-12H2,1H3,(H,32,35)(H2,27,28,29,30,31) URLRQHFQZGIRSB-UHFFFAOYSA-N 660482 US20240092799, Compound XXIX-AAJ MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660482 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660482&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053849 496708973 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391095 CN1CCC(CC1)c1ccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3O)ncn2)nc1 InChI=1S/C28H34N8O2/c1-18-14-24(36(38)26-25(18)27(37)34-28(26)10-4-3-5-11-28)33-23-15-22(30-17-31-23)32-21-7-6-20(16-29-21)19-8-12-35(2)13-9-19/h6-7,14-17,19,38H,3-5,8-13H2,1-2H3,(H2,29,30,31,32,34,37)/p+1 IVRCFUBIWCALAK-UHFFFAOYSA-O 660483 US20240092799, Compound XXIX-AAK MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660483 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660483&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053880 496708974 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391096 Cc1cc(Nc2cc(Nc3ccc(cn3)N3CCNCC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C26H31N9O2/c1-17-13-22(35(37)24-23(17)25(36)33-26(24)7-3-2-4-8-26)32-21-14-20(29-16-30-21)31-19-6-5-18(15-28-19)34-11-9-27-10-12-34/h5-6,13-16,27H,2-4,7-12H2,1H3,(H,33,36)(H2,28,29,30,31,32) HJOFHVJIMISXHM-UHFFFAOYSA-N 660484 US20240092799, Compound XXIX-AAL MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660484 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660484&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086780 496708975 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391097 Cc1cc(Nc2cc(Nc3ccc(cn3)N3CCCCC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C27H32N8O2/c1-18-14-23(35(37)25-24(18)26(36)33-27(25)10-4-2-5-11-27)32-22-15-21(29-17-30-22)31-20-9-8-19(16-28-20)34-12-6-3-7-13-34/h8-9,14-17H,2-7,10-13H2,1H3,(H,33,36)(H2,28,29,30,31,32) UOGYUIRMCWDDHQ-UHFFFAOYSA-N 660485 US20240092799, Compound XXIX-AAM MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660485 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660485&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086928 496708976 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391098 C[C@H]1CN(C[C@@H](C)N1)c1ccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)nc1 |r| InChI=1S/C28H35N9O2/c1-17-11-24(37(39)26-25(17)27(38)35-28(26)9-5-4-6-10-28)34-23-12-22(30-16-31-23)33-21-8-7-20(13-29-21)36-14-18(2)32-19(3)15-36/h7-8,11-13,16,18-19,32H,4-6,9-10,14-15H2,1-3H3,(H,35,38)(H2,29,30,31,33,34) CANCBTRNOZFMTO-UHFFFAOYSA-N 660486 US20240092799, Compound XXIX-AAN MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660486 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660486&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086892 496708977 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391099 CCN1CCN(CC1)c1ccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)nc1 InChI=1S/C28H35N9O2/c1-3-35-11-13-36(14-12-35)20-7-8-21(29-17-20)32-22-16-23(31-18-30-22)33-24-15-19(2)25-26(37(24)39)28(34-27(25)38)9-5-4-6-10-28/h7-8,15-18H,3-6,9-14H2,1-2H3,(H,34,38)(H2,29,30,31,32,33) JYSPKGKMQRIABH-UHFFFAOYSA-N 660487 US20240092799, Compound XXIX-AAO MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660487 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660487&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086897 496708978 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391100 Cc1cc(Nc2cc(Nc3ccc(cn3)N3CCN(CCO)CC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C28H35N9O3/c1-19-15-24(37(40)26-25(19)27(39)34-28(26)7-3-2-4-8-28)33-23-16-22(30-18-31-23)32-21-6-5-20(17-29-21)36-11-9-35(10-12-36)13-14-38/h5-6,15-18,38H,2-4,7-14H2,1H3,(H,34,39)(H2,29,30,31,32,33) QVWWDDWAKPNTHY-UHFFFAOYSA-N 660488 US20240092799, Compound XXIX-AAP MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660488 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660488&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 171053888 496708979 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391101 CC(C)n1ccc(Nc2cc(Nc3cc(C)c4C(=O)NC5(CCCCC5)c4[n+]3[O-])ncn2)n1 InChI=1S/C23H28N8O2/c1-14(2)30-10-7-16(29-30)26-17-12-18(25-13-24-17)27-19-11-15(3)20-21(31(19)33)23(28-22(20)32)8-5-4-6-9-23/h7,10-14H,4-6,8-9H2,1-3H3,(H,28,32)(H2,24,25,26,27,29) LVOUNPFOYCFZNY-UHFFFAOYSA-N 660489 US20240092799, Compound XXIX-AAQ MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660489 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660489&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086901 496708980 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391102 Cc1cc(Nc2cc(Nc3ccnn3C3CCNCC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 InChI=1S/C25H31N9O2/c1-16-13-21(34(36)23-22(16)24(35)32-25(23)8-3-2-4-9-25)31-19-14-18(27-15-28-19)30-20-7-12-29-33(20)17-5-10-26-11-6-17/h7,12-15,17,26H,2-6,8-11H2,1H3,(H,32,35)(H2,27,28,30,31) WDMUDILQQQGUQQ-UHFFFAOYSA-N 660490 US20240092799, Compound XXIX-AAR MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660490 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660490&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086853 496708981 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391103 Cc1cc(Nc2cc(Nc3ccc(cn3)C3=CCOCC3)ncn2)[n+]([O-])c2c1C(=O)NC21CCCCC1 |t:16| InChI=1S/C27H29N7O3/c1-17-13-23(34(36)25-24(17)26(35)33-27(25)9-3-2-4-10-27)32-22-14-21(29-16-30-22)31-20-6-5-19(15-28-20)18-7-11-37-12-8-18/h5-7,13-16H,2-4,8-12H2,1H3,(H,33,35)(H2,28,29,30,31,32) CTXPHGLHDJEXPL-UHFFFAOYSA-N 660491 US20240092799, Compound XXIX-AAS MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660491 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660491&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086876 496708982 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391104 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4cccnc34)sc12 InChI=1S/C18H17N5OS/c24-17-15-11(18(23-17)6-2-1-3-7-18)9-13(25-15)22-16-14-12(20-10-21-16)5-4-8-19-14/h4-5,8-10H,1-3,6-7H2,(H,23,24)(H,20,21,22) JOFFGZLFYBSPBO-UHFFFAOYSA-N 660492 US20240092799, Compound XXX MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660492 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660492&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 163685137 496708983 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391105 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4NCCc34)sc12 InChI=1S/C17H19N5OS/c23-16-13-11(17(22-16)5-2-1-3-6-17)8-12(24-13)21-15-10-4-7-18-14(10)19-9-20-15/h8-9H,1-7H2,(H,22,23)(H2,18,19,20,21) XBZSSTXNEPUJAK-UHFFFAOYSA-N 660493 US20240092799, Compound XXXI MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660493 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660493&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 164086174 496708984 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391106 O=C1NC2(CCCCC2)c2cc(Nc3ncnc4[nH]c(cc34)C3CC3)sc12 InChI=1S/C20H21N5OS/c26-19-16-13(20(25-19)6-2-1-3-7-20)9-15(27-16)24-18-12-8-14(11-4-5-11)23-17(12)21-10-22-18/h8-11H,1-7H2,(H,25,26)(H2,21,22,23,24) UERQDKNVBPJSAR-UHFFFAOYSA-N 660494 US20240092799, Compound XXXI-A MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 5.5 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660494 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660494&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086825 496708985 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6 1391107 Cn1cnc(Nc2cc(Nc3cc4c(s3)C(=O)NC43CCCCC3)ncn2)c1 InChI=1S/C19H21N7OS/c1-26-9-15(22-11-26)23-13-8-14(21-10-20-13)24-16-7-12-17(28-16)18(27)25-19(12)5-3-2-4-6-19/h7-11H,2-6H2,1H3,(H,25,27)(H2,20,21,23,24) GAZVIFCOGLYLEJ-UHFFFAOYSA-N 660495 US20240092799, Compound XXXI-B MAP kinase-interacting serine/threonine-protein kinase 2 Homo sapiens 55 US Patent 10.7270/Q2GH9P7Z aid1963533 US20240092799 MO, C; Xu, X 3/21/2024 6/4/2024 Hepagene Therapeutics (Hk http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=660495 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5506&target=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=660495&enzyme=MAP+kinase-interacting+serine%2Fthreonine-protein+kinase+2&column=ki&startPg=0&Increment=50&submit=Search 169086832 496708986 1 MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA 8XFM,9HRC,8P9B,6CKI,6CK6,6CK3,6CJY,6CJW,6CJH,6CJE,6CJ5,2HW7,2AC5 MAP kinase-interacting serine/threonine-protein kinase 2 MKNK2_HUMAN Q9HBH9 Q6GPI3 Q9HBH8 Q9UHR0 Q9Y2N6